Neuralink widens its patient trial as brain-computer interfaces edge toward a real market
Neuralink has expanded the number of patients implanted with its brain-computer interface device this year, extending beyond its initial small cohort of participants with severe paralysis into a broader trial population and, in a notable expansion, patients using the device for applications beyond c
Source: The Information